Andelyn Biosciences

In March 2006, Dr. Mendell injected the first U.S. investigational gene therapy for Duchenne muscular dystrophy into the arm muscle of a young boy with DMD. That boy was Andrew Kilbarger. The injection, using an adeno-associated virus (AAV)-mediated vector, delivered microdystrophin to the muscle producing a functional protein that reduced muscle deterioration. “Andrew is so important because his injections proved the safety and efficacy of this therapy,” Dr. Mendell explains. Today, we unite in the fight against Duchenne muscular dystrophy. The strength and resilience of Andrew Kilbarger and Dr. Mendell and his team represents a beacon of hope, saving lives and paving the way for a brighter future. To learn more about Duchenne and get involved, visit https://buff.ly/3yZ1G7r #AndelynBiosciences #DuchenneMuscularDystrophy #WDAD2024

At Andelyn Biosciences, we believe in the power of experience, know-how, and precision. Our modern facilities, designed for today’s highest quality rigor, and team of seasoned scientists are at the forefront of AAV gene therapy, offering reliable expertise in process development and cGMP manufacturing. Start working with us with a small-scale feasibility study and generate the data to drive decisions for your critical roadmap to clinical and commercial manufacturing. Learn more about our feasibility study offer here https://buff.ly/3A0hTJT #AndelynBiosciences #GeneTherapy #CDMO

Andelyn Biosciences collaborates closely with you throughout the development process to establish a dependable and high quality clinical and commercial material. We support you at every step. Learn more about our viral vector manufacturing: https://buff.ly/4dHYV9K #AndelynBiosciences #GeneTherapy #ViralVectorManufacturing

The path to advancing healthcare through gene therapy is both exciting and complex. At Andelyn Biosciences, we’re not just part of this journey; we’re leading the way with expertise and reliable manufacturing. Whether you are in need of tech transferring the manufacturing of your program or looking for development and scale up into Andelyn’s AAV Curator™ Platform, let us work together to shape a hopeful future for patients in need of life-altering therapies. Learn more about our feasibility studies as a first step into a partnership defined by expertise and close collaboration. https://buff.ly/3A0hTJT #AndelynBiosciences #GeneTherapy #CDMO #AAVCuratorPlatform

Our journey began at Nationwide Children's Hospital, leading to the discovery of the first FDA-approved systemic gene therapy. Today, we stand ready as your reliable partner, equipped with the expertise and scalable solutions to bring your therapies from concept to commercialization. Get in touch and discover how we can contribute to your long-term success with a low risk feasibility study: https://buff.ly/3UzqzNP #andelynbiosciences

With over 20 years of experience in cell and gene therapy manufacturing, Andelyn understands how plasmids can impact vector packaging performance. Through a close collaboration between the plasmid and vector teams, clients can leverage our extensive expertise for vector design consultation and optimization. Learn more about our plasmid manufacturing: https://buff.ly/3WUPVqG #AndelynBiosciences #GeneTherapy #PlasmidManufacturing

Andelyn Biosciences is excited to announce we are hosting an Inaugural Golf Tournament on September 30, 2024 at The Country Club at Muirfield Village. Join us FORE One Purpose to raise both awareness and funds for the gene therapy and rare disease community we support. Learn more about how you can participate here: https://lnkd.in/gRQSMnst #andelynbiosciences #genetherapy

In an industry where change is ever constant, Andelyn Biosciences stands as your steadfast partner in gene therapy manufacturing. With over two decades of experience and expertise, our commitment to growth and innovation ensures we're here for you, ready to bring your groundbreaking therapies from the lab to the patient. See what a feasibility study and yield assessment can do to get your program started on a path to process industrialization: https://buff.ly/3UzqzNP #andelynbiosciences

Andelyn Biosciences supports clients from preclinical concept to commercialization. We have supported more than 75 INDs with successful completion of over 450 cGMP clinical batches and over 2,000 research grade batches. Head to our website to learn about all of our capabilities: https://lnkd.in/ep8wf7ma #AndelynBiosciences #CDMO #GeneTherapy https://lnkd.in/eNwkza4x

Are you in need of finding a home for the manufacturing of your AAV Program? Decades of AAV experience and production data allows us to know which process parameter and manufacturing technology levers to pull to quickly optimize your process. Through Optimization-By-Design™ we strike the right balance between yield and purity for the advancement of your program. Learn more about our feasibility studies as a first step into a partnership defined by expertise and trust: https://buff.ly/3A0hTJT #AndelynBiosciences #GeneTherapy #CDMO